The Macfarlanes Team successfully defended a claim for fraudulent misrepresentation and conspiracy against entities in the BGF Group and one of its employees after a three-week...
BGF Group’s Win the Fraudulent Misrepresentation Dispute in Commercial Court
Diageo Plc’s Delisting From Euronext Paris and Dublin
Slaughter and May advised Diageo Plc on the voluntary delisting of its shares from euronext Paris and euronext Dublin. Further to the announcements made on 13...
Glenstone REIT’s Acquisition of Prominent Industrial Site in Birmingham
Knights advised one of the UK’s leading Real Estate Investment Trusts on its purchase of a prominent industrial site near Birmingham city centre through the acquisition...
Fimatix’s Acquisition of Semantic Evolution
Knights’ Corporate team advised Fimatix inhis acquisition of Semantic Evolution Limited, a specialist in the provision of AI and machine learning powered solutions to the financial...
Starry Group Holdings’ Plan of Reorganization
Latham & Watkins advises Starry Group Holdings on uncontested plan of reorganization. Starry Group Holdings, Inc., a fixed wireless broadband internet service provider, received confirmation by...
Clearway Energy Group’s Financing and Sale of California Solar and Storage Projects
Latham & Watkins advising Clearway Energy Group in financing and sale of California Solar and Storage Projects Clearway Energy Group, LLC closed approximately US$1 billion of debt...
eFFECTOR Therapeutics’ $7.5 Million Registered Direct Offering
Latham & Watkins advises eFFECTOR Therapeutics in US$7.5 million registered direct offering. eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs)...
TUI’s €2.7 Billion Credit Lines Extension Until 2026
Latham & Watkins has advised the bank consortium on the maturity extension of the €2.7 billion revolving credit facilities (RCF) for travel group TUI by a...
TA Associates Strategic Growth Investment in Alpha II
Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
U.S. Physical Therapy’s $150 Million Common Stock Offering
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
Ecovyst’s Secondary Offering of Common Stock Shares
Latham & Watkins advised the underwriters on Ecovyst’s secondary offering of 14,000,000 shares of common stock by a selling stockholder and repurchase of common stock. Ecovyst...